Odendaal, WChetty, TSchneider, HGoga, A2024-08-112024-08-112022-10-18https://hdl.handle.net/11288/597162Poster presentation at 38TH International Society for Quality in Health Care (ISQUA). AUSTRALIA, 18-20 October 2022.Synopsis of poster Introduction: SA Department of Health leads a multi-partner MNH quality improvement (QI) programme (2018-2022), called Mphatlalatsane, to reduce maternal - and neonatal mortality and stillbirth rates in three provinces. Objective: To identify the facility level implementation processes and contextual factors, including COVID-19, that explain variation in the uptake and outcomes of Mphatlalatsane, and their implications for scale-up. Results: The following contextual factors, in order of importance, are shaping the uptake of the QI methodology. (1) Lead time before COVID-19 (2) Leadership (3) Embedding QI work in standard care Conclusion: Taking Mphatlalatsane to scale will require identifying team leaders who buy into QI methodology and have the skills to foster teamwork. The programme should be introduced as supporting staff to do what they are supposed to do, and not as external to standard care.enAttribution 3.0 United Stateshttp://creativecommons.org/licenses/by/3.0/us/Maternal healthNeonatal healthHealth servicesCOVID-19Other